
The main areas of cooperation between the two regulatory authorities include exchange of safety information, including pharmacovigilance where there is a particular safety concern related to the other party.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3epMgu6
via
IFTTT
0 comments:
Post a Comment